Lobby organisation
Bristol-Myers Squibb Company
Business / industry · Health & pharma · HQ: United States · Transparency Register entry
As of 9 September 2026, Bristol-Myers Squibb Company appears in 39 declared MEP meetings (27 different MEPs), most often with European People's Party.
In their own words
“Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.”
Stated goals from the organisation's own Transparency Register filing.
Who they meet, and when
Which groups they meet
Share of this organisation's 39 declared meetings, by the meeting MEP's political group.
Meetings by year
Declared meetings per calendar year, 2022–2026. Bar length is relative to its busiest year (19 in 2025).
Group is each MEP's current political group, not necessarily the one they sat with at the time. Shares are rounded to whole percent.
The MEPs they meet most
The 15 most recent declared meetings
| Date | MEP | Subject |
|---|---|---|
| 17 Jun 2026 | Ruggero Razza | Incontro conoscitivo su tematiche SANT |
| 3 Jun 2026 | Lukas Mandl | Biotech Act I |
| 11 May 2026 | András Tivadar Kulja | Biotech |
| 7 May 2026 | Tomislav Sokol | Health Policy |
| 6 May 2026 | Tiemo Wölken | Biotech Act |
| 28 Apr 2026 | Ingeborg ter Laak | Biotech Act |
| 22 Apr 2026 | Vytenis Povilas Andriukaitis | Biotech act |
| 16 Apr 2026 | Wouter Beke | Biotech Act I |
| 26 Mar 2026 | Stine Bosse | Biotech Act |
| 24 Feb 2026 | Carlo Ciccioli | Biotech act |
| 25 Nov 2025 | Andi Cristea | Recent developments in EU-US trade policy |
| 20 Nov 2025 | Michele Picaro | Meeting |
| 8 Oct 2025 | Victor Negrescu | AmCham EU Healthcare Committee Meeting |
| 8 Oct 2025 | Hildegard Bentele | Biotech |
| 1 Oct 2025 | Andreas Glück | CMA |
Meeting an MEP is a normal part of democratic life; the record is shown so anyone can see it.